![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
Rallybio ends development in rare disorder; ImmunityBio raises $75M
Plus, news about KalVista, Kaken Pharmaceutical, Lyell and Tango Therapeutics: Rallybio stops work on RLYB212 in rare immune disorder: The company had been testing the drug to see if it could prevent fetal and neonatal ...
Plus, news about KalVista, Kaken Pharmaceutical, Lyell and Tango Therapeutics:
Rallybio stops work on RLYB212 in rare immune disorder: The company had been testing the drug to see if it could prevent fetal and neonatal ...
